Source:http://linkedlifedata.com/resource/pubmed/id/17878156
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
46
|
pubmed:dateCreated |
2007-11-12
|
pubmed:abstractText |
We have demonstrated that bronchoalveolar lavage fluid from chronic obstructive pulmonary disease patients contains higher levels of interferon-gamma compared with controls. Interferon-gamma is a potent inducer of various cathepsins and matrix metalloproteases. Therefore, we postulated that interferon-gamma could induce protease expression by macrophages in acute and chronic lung disease. Chronic obstructive pulmonary disease patients had greater levels of cathepsin S and matrix metalloprotease-12 in their bronchoalveolar lavage fluid. Macrophages incubated with chronic obstructive pulmonary disease bronchoalveolar lavage fluid exhibited increased expression of cathepsin S and matrix metalloprotease-12, which was inhibited by the addition of interferon-gamma-neutralizing immunoglobulin. Human secretory leukocyte protease inhibitor is an 11.7-kDa cationic non-glycosylated antiprotease synthesized and secreted by cells at the site of inflammation. We have demonstrated that secretory leukocyte protease inhibitor can inhibit interferon-gamma-induced cathepsin S production by macrophages. Pretreatment of macrophages with secretory leukocyte protease inhibitor inhibited interferon-gamma-induced inhibitor kappaB beta degradation and activation of nuclear factor kappaB. Secretory leukocyte protease inhibitor may prove to be therapeutically important as a potential inhibitor of protease expression in chronic obstructive pulmonary disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cathepsins,
http://linkedlifedata.com/resource/pubmed/chemical/Cations,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 12,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Secretory Leukocyte Peptidase...,
http://linkedlifedata.com/resource/pubmed/chemical/cathepsin S
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
282
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33389-95
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17878156-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:17878156-Cathepsins,
pubmed-meshheading:17878156-Cations,
pubmed-meshheading:17878156-Gene Expression Regulation,
pubmed-meshheading:17878156-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:17878156-Humans,
pubmed-meshheading:17878156-Interferon-gamma,
pubmed-meshheading:17878156-Leukocytes, Mononuclear,
pubmed-meshheading:17878156-Macrophages,
pubmed-meshheading:17878156-Matrix Metalloproteinase 12,
pubmed-meshheading:17878156-NF-kappa B,
pubmed-meshheading:17878156-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:17878156-Secretory Leukocyte Peptidase Inhibitor,
pubmed-meshheading:17878156-Subcellular Fractions,
pubmed-meshheading:17878156-U937 Cells
|
pubmed:year |
2007
|
pubmed:articleTitle |
Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression.
|
pubmed:affiliation |
Pulmonary Research Division, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin 9, Ireland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|